guest ::
| Home > Publications Database > Dataset: Mapping of TDP-43 ubiquitination and acetylation sites > print |
| Home > Publications Database > Dataset: Mapping of TDP-43 ubiquitination and acetylation sites > print |
| 001 | 195005 | ||
| 005 | 20240118173321.0 | ||
| 037 | _ | _ | |a DZNE-2023-00188 |
| 100 | 1 | _ | |a Gloeckner, Christian Johannes |0 P:(DE-2719)2811291 |b 0 |e Corresponding author |u dzne |
| 245 | _ | _ | |a Dataset: Mapping of TDP-43 ubiquitination and acetylation sites |
| 260 | _ | _ | |c 2022 |b PRoteomics IDEntifications Database |
| 336 | 7 | _ | |a MISC |2 BibTeX |
| 336 | 7 | _ | |a Dataset |b dataset |m dataset |0 PUB:(DE-HGF)32 |s 1705595583_9224 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Chart or Table |0 26 |2 EndNote |
| 336 | 7 | _ | |a Dataset |2 DataCite |
| 336 | 7 | _ | |a DATA_SET |2 ORCID |
| 336 | 7 | _ | |a ResearchData |2 DINI |
| 520 | _ | _ | |a TAR DNA binding protein of 43 kDa (TDP-43) forms aggregates in neurodegenerative diseases, particularly certain forms of frontotemporal dementia and amyotrophic lateral sclerosis. Pathological modifications of TDP-43 include proteolytic fragmentation, phosphorylation, and ubiquitinylation. In this study, we systematically mapped TDP-42 ubiquitination as well as acetylation sites. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 787 | 0 | _ | |a Garcia Morato, Jorge et.al. |d [London] : Nature Publishing Group UK, 2022 |i RelatedTo |0 DZNE-2022-00033 |r |t Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43. |
| 856 | 4 | _ | |u https://www.ebi.ac.uk/pride/archive/projects/PXD030170 |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:195005 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811291 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2022 |
| 920 | 1 | _ | |0 I:(DE-2719)1210007 |k AG Gloeckner |l Functional Neuroproteomics and Translational Biomarkers in Neurodegenerative Diseases |x 0 |
| 980 | _ | _ | |a dataset |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1210007 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|